Sila Earns ISO 9001:2015 Certification, A Key Requirement of Global Automakers and Consumer Electronics Companies
Milestone is a commitment to operational excellence, product integrity, and customer satisfaction as Sila scales…
News
Neuronetics Recognized as Top Non-Invasive Devices Provider in 2022
Technology is awarded for its innovation to treat depression with NeuroStar Advanced Therapy for Mental…
Healthy Extracts Reports Preliminary Q2 2022 Results
LAS VEGAS, July 13, 2022 (GLOBE NEWSWIRE) — Healthy Extracts’ (OTCQB: HYEX) reported record preliminary unaudited…
CytoDyn Appoints Cyrus Arman, Ph.D., MBA, as President
VANCOUVER, Washington, July 13, 2022 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the…
BioCorRx to Participate in the Benzinga All Access Event on July 15th
ANAHEIM, CA, July 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – BioCorRx Inc. (OTCQB: BICX)…
ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update
FREMONT, CA, July 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ:…
The GBT Foundation Awards $250,000 in ACE Grants to Support Sickle Cell Disease Community-Based Organizations
SOUTH SAN FRANCISCO, Calif., July 13, 2022 (GLOBE NEWSWIRE) — The GBT Foundation, a 501(c)(3)…
Alimera Announces Data to Be Highlighted In Scientific Programming At Annual Congress
ILUVIEN® data to be presented onsite at the annual American Society of Retina Specialists (ASRS)…
scPharmaceuticals Inc. to Participate in the Maxim Group LLC Late-Stage Advancements in Heart Failure Therapeutics and Management Panel Discussion
BURLINGTON, Mass., July 13, 2022 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company…
Spectral Medical to Participate at the Benzinga All Access event on July 15, 2022
TORONTO, July 13, 2022 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022
SEATTLE, July 13, 2022 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a…
Certara Appoints Eran Broshy as New Independent Board Member
PRINCETON, N.J., July 13, 2022 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader…
NICE Issues Final Guidance for Reimbursement Making VAZKEPA® (icosapent ethyl) Available Across the NHS in England & Wales
— Newly published final guidance by the National Institute for Health and Care Excellence (NICE)…
Theratechnologies Announces Binding Commitment for a Non-Dilutive Term Loan of up to $100 million from Marathon Asset Management
Financing Will Significantly Strengthen the Balance Sheet and Extend Cash Runway Initial Draw of $40…
Cronos Group Inc. to Hold 2022 Second Quarter Earnings Conference Call on August 9, 2022
TORONTO, July 13, 2022 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”…
Dr. Sergey Motov at Maimonides Medical Center to Host Webinar on using MeMed BV® in the Emergency Department to rapidly differentiate bacterial and viral infections
Dr. Sergey Motov at Maimonides Medical Center to Host Webinar on using MeMed BV® in…
PharmaTher Announces Notice of Allowance for U.S. Patent Covering Ketamine for the Potential Treatment of Parkinson’s Disease and Motor Disorders
TORONTO, July 13, 2022 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB:…
Optinose Announces that XHANCE Significantly Reduced Incidence of Exacerbations for Patients with Chronic Sinusitis in Landmark ReOpen Program
XHANCE is the first and only nasal medication ever shown in Phase 3 controlled trialsto…
Plus Therapeutics to Announce Second Quarter 2022 Financial Results and Host Conference Call on July 21, 2022
AUSTIN, Texas, July 13, 2022 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
XORTX Announces Positive Topline Results from Pharmacokinetics Bridging Clinical Trial
Clinical Trial Shows Substantially Improved Bioavailiability CALGARY, Alberta, July 13, 2022 (GLOBE NEWSWIRE) — XORTX…